Frederick G Hayden1. Show Affiliations » 1. Division of Infectious Diseases and International Health, Department of Internal Medicine, University of Virginia School of Medicine, Charlottesville, USA.
Abstract
Mesh: See more » Amantadine/pharmacologyAmantadine/therapeutic useAntiviral Agents/pharmacologyAntiviral Agents/therapeutic useDisease Outbreaks/prevention & controlDrug Resistance, ViralHumansInfluenza A Virus, H3N2 Subtype/drug effectsInfluenza A Virus, H3N2 Subtype/geneticsInfluenza A Virus, H3N2 Subtype/physiologyInfluenza, Human/drug therapyInfluenza, Human/epidemiologyMutationNeuraminidase/antagonists & inhibitorsNucleic Acid Synthesis Inhibitors/pharmacologyNucleic Acid Synthesis Inhibitors/therapeutic useRimantadine/pharmacologyRimantadine/therapeutic useViral Matrix Proteins/antagonists & inhibitorsVirus Replication/drug effects
Substances: See more » Antiviral AgentsM2 protein, Influenza A virusNucleic Acid Synthesis InhibitorsViral Matrix ProteinsRimantadineAmantadineNeuraminidase
Year: 2006 PMID: 16495389 DOI: 10.1056/NEJMp068030
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245